Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering

MLA

Paul R. Stabach, et al. “Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering.” Clinical and Translational Science, vol. 14, no. 1, Jan. 2021, pp. 362–72. EBSCOhost, https://doi.org/10.1111/cts.12887.

APA

Paul R. Stabach, Kristin Zimmerman, Aaron Adame, Dillon Kavanagh, Christopher T. Saeui, Christian Agatemor, Shawn Gray, Wenxiang Cao, Enrique M. De La Cruz, Kevin J. Yarema, & Demetrios T. Braddock. (2021). Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering. Clinical and Translational Science, 14(1), 362–372. https://doi.org/10.1111/cts.12887

Chicago

Paul R. Stabach, Kristin Zimmerman, Aaron Adame, Dillon Kavanagh, Christopher T. Saeui, Christian Agatemor, Shawn Gray, et al. 2021. “Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering.” Clinical and Translational Science 14 (1): 362–72. doi:10.1111/cts.12887.